基于遗传算法增强的人工神经网络CT放射组学特征无创预测结直肠癌微卫星不稳定状态
本研究从两家医院纳入837例术前行增强CT且有微卫星不稳定(MSI)状态数据的结直肠癌患者,提取放射组学特征并用遗传算法增强的人工神经网络构建MSI相关放射组学特征。该特征在内外部验证队列中AUC分别为0.788和0.775,与联合模型(AUC 0.777和0.767)性能相当,优于由年龄和肿瘤位置构成的临床模型(AUC 0.768和0.623)。生存分析显示该特征可对II期结直肠癌患者进行预后分层(HR 0.402,p=0.029)。
要点
- CT放射组学特征可在术前无创预测结直肠癌MSI状态,内部验证AUC 0.788、外部验证AUC 0.775。
- 该特征性能与联合临床因素的联合模型相当,并优于仅含年龄和肿瘤位置的临床模型。
- 该特征可对II期结直肠癌患者进行预后分层(HR 0.402,p=0.029)。
核心结论
- 基于遗传算法增强人工神经网络的CT放射组学特征能稳健识别结直肠癌MSI状态,可能辅助个体化治疗决策。
研究设计与样本
- 回顾性研究,从两家医院纳入837例术前行增强CT且有MSI状态数据的结直肠癌患者,提取分割肿瘤的放射组学特征,采用数据平衡与特征选择策略,以遗传算法增强的人工神经网络构建MSI相关放射组学特征,并用多因素logistic回归构建联合模型和临床模型。
诊断标准与关键数值
- 放射组学特征由10个特征构成,内部验证队列AUC 0.788,外部验证队列AUC 0.775。
- 联合模型内部验证AUC 0.777、外部验证AUC 0.767,与放射组学特征性能相当。
- 由年龄和肿瘤位置构成的临床模型内部验证AUC 0.768、外部验证AUC 0.623,放射组学特征优于该临床模型。
- 生存分析中该特征对II期结直肠癌预后分层HR 0.402(p=0.029)。
临床应用与阅片要点
- 原文结论认为该放射组学特征可能辅助结直肠癌患者的个体化治疗决策。
- 原文指出精心设计的建模策略有助于克服MSI低发生率导致的数据不平衡问题。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The stratification of microsatellite instability (MSI) status assists clinicians in making treatment decisions for colorectal cancer (CRC) patients. This study aimed to establish a CT-based radiomics signature to predict MSI status in patients with CRC.
METHODS: A total of 837 CRC patients who underwent preoperative enhanced CT and had available MSI status data were recruited from two hospitals. Radiomics features were extracted from segmented tumours, and a series of data balancing and feature selection strategies were used to select MSI-related features. Finally, an MSI-related radiomics signature was constructed using a genetic algorithm-enhanced artificial neural network model. Combined and clinical models were constructed using multivariate logistic regression analyses by integrating the clinical factors with or without the signature. A Kaplan-Meier survival analysis was conducted to explore the prognostic information of the signature in patients with CRC.
RESULTS: Ten features were selected to construct a signature which showed robust performance in both the internal and external validation cohorts, with areas under the curves (AUC) of 0.788 and 0.775, respectively. The performance of the signature was comparable to that of the combined model (AUCs of 0.777 and 0.767, respectively) and it outperformed the clinical model constituting age and tumour location (AUCs of 0.768 and 0.623, respectively). Survival analysis demonstrated that the signature could stratify patients with stage II CRC according to prognosis (HR: 0.402, p = 0.029).
CONCLUSIONS: This study built a robust radiomics signature for identifying the MSI status of CRC patients, which may assist individualised treatment decisions.
KEY POINTS: • Our well-designed modelling strategies helped overcome the problem of data imbalance caused by the low incidence of MSI. • Genetic algorithm-enhanced artificial neural network-based CT radiomics signature can effectively distinguish the MSI status of CRC patients. • Kaplan-Meier survival analysis demonstrated that our signature could significantly stratify stage II CRC patients into high- and low-risk groups.
引用
- Chen, He, Li, et al. Non-invasive prediction of microsatellite instability in colorectal cancer by a genetic algorithm-enhanced artificial neural network-based CT radiomics signature. Eur Radiol. 2022. PMID: 35771245. doi:10.1007/s00330-022-08954-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。